Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients

Running, not enrolling

Conditions studied: HIV-1 Infection, Receipt of Cal-1 Modified Hematopoietic Cellular Products

In brief

Long term safety follow-up of Cal-1 recipients

Key facts

Study ID

NCT02390297

Run by

Calimmune, Inc.

People needed

11

Starts

2015-04-01

Expected to finish

2031-10-01

Last updated by the study team

2025-10-10

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Signed informed consent
• Previous treatment with the Cal-1 modified hematopoietic cellular products

You may not qualify if…

• Inability to understand and provide informed consent

Where it is running

• UCLA CARE Center — Los Angeles, California, United States
• Quest Clinical Research — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.